6-Amino-1-(furan-2-ylmethyl)-2,4-dioxo-1,2,3,4-tetrahydropyrimidine-5-carbaldehyde
- $525 - $790
- Product name: 6-Amino-1-(furan-2-ylmethyl)-2,4-dioxo-1,2,3,4-tetrahydropyrimidine-5-carbaldehyde
- CAS: 890095-55-3
- MF: C10H9N3O4
- MW: 235.2
- EINECS:
- MDL Number:
- Synonyms:6-Amino-1-(furan-2-ylmethyl)-2,4-dioxo-1,2,3,4-tetrahydropyrimidine-5-carbaldehyde;5-Pyrimidinecarboxaldehyde, 6-amino-1-(2-furanylmethyl)-1,2,3,4-tetrahydro-2,4-dioxo-
3 prices
Selected condition:
Brand
- Chemenu
- Crysdot
- TRC
Package
- 250mg
- 1g
- ManufacturerChemenu
- Product numberCM315169
- Product description6-Amino-1-(Furan-2-ylmethyl)-2,4-dioxo-1,2,3,4-tetrahydropyrimidine-5-carbaldehyde 95%
- Packaging1g
- Price$746
- Updated2021-12-16
- Buy
- ManufacturerCrysdot
- Product numberCD11028646
- Product description6-Amino-1-(Furan-2-ylmethyl)-2,4-dioxo-1,2,3,4-tetrahydropyrimidine-5-carbaldehyde 95+%
- Packaging1g
- Price$790
- Updated2021-12-16
- Buy
- ManufacturerTRC
- Product numberA609845
- Product description6-Amino-1-(furan-2-ylmethyl)-2,4-dioxo-1,2,3,4-tetrahydropyrimidine-5-carbaldehyde
- Packaging250mg
- Price$525
- Updated2021-12-16
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
Chemenu | CM315169 | 6-Amino-1-(Furan-2-ylmethyl)-2,4-dioxo-1,2,3,4-tetrahydropyrimidine-5-carbaldehyde 95% | 1g | $746 | 2021-12-16 | Buy |
Crysdot | CD11028646 | 6-Amino-1-(Furan-2-ylmethyl)-2,4-dioxo-1,2,3,4-tetrahydropyrimidine-5-carbaldehyde 95+% | 1g | $790 | 2021-12-16 | Buy |
TRC | A609845 | 6-Amino-1-(furan-2-ylmethyl)-2,4-dioxo-1,2,3,4-tetrahydropyrimidine-5-carbaldehyde | 250mg | $525 | 2021-12-16 | Buy |
Properties
storage temp. :Hygroscopic, -20°C Freezer, Under inert atmosphere
solubility :DMSO (Sparingly, Heated)
form :Solid
color :Light Orange to Dark Orange
solubility :DMSO (Sparingly, Heated)
form :Solid
color :Light Orange to Dark Orange
Safety Information
Symbol(GHS): | ||||||||
---|---|---|---|---|---|---|---|---|
Signal word: | ||||||||
Hazard statements: |
|
|||||||
Precautionary statements: |
|